Zimmer Stock Gains On Ortho Procedure Volume; S&N Also Up – Index
This article was originally published in The Gray Sheet
Orthopedic implant maker Zimmer's stock is benefiting in part from a recent boost in reconstructive implant procedure volumes and investor optimism for 2008-09
You may also be interested in...
Covidien gains the Permacol biologic tissue repair implant for hernias and other applications through its $80 million purchase of Tissue Science Laboratories, announced March 12
Inverness Medical Innovations will continue to expand beyond its rapid point-of-care diagnostics business and into the health management services sector through its $1.18 billion acquisition of Matria Healthcare, announced Jan. 28
Stryker is raising its stake in compliance activities in response to government scrutiny of its regulatory and sales practices, but the firm does not foresee a major hit to its bottom line